Cargando…
FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth
Liver kinase B1 (LKB1) regulates both cell growth and energy metabolism. Inactivated mutations of LKB1, observed in 20–30% of nonsmall cell lung cancers (NSCLC), contribute significantly to lung cancer malignancy progression. However, the upstream signalings regulating LKB1 activity remain incomplet...
Autores principales: | Zhu, Xiao-Na, He, Ping, Zhang, Liang, Yang, Shuo, Zhang, Hui-Lin, Zhu, Di, Liu, Meng-Di, Yu, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584689/ https://www.ncbi.nlm.nih.gov/pubmed/31217475 http://dx.doi.org/10.1038/s41419-019-1732-9 |
Ejemplares similares
-
F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression
por: Tian, Xin, et al.
Publicado: (2015) -
F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells
por: Wu, Bo, et al.
Publicado: (2017) -
FBXO22 degrades nuclear PTEN to promote tumorigenesis
por: Ge, Meng-Kai, et al.
Publicado: (2020) -
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
por: Zhu, Xiao-Na, et al.
Publicado: (2023) -
HSP90 promotes radioresistance of cervical cancer cells via reducing FBXO6‐mediated CD147 polyubiquitination
por: Song, Qi, et al.
Publicado: (2022)